PureTech Health (LON:PRTC) Stock Crosses Below 50 Day Moving Average – Here’s Why

PureTech Health plc (LON:PRTC)’s share price crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 128.56 and traded as low as GBX 125. PureTech Health shares last traded at GBX 129.40, with a volume of 239,601 shares traded.

Analysts Set New Price Targets

Separately, Peel Hunt reiterated a “buy” rating and issued a GBX 508 price target on shares of PureTech Health in a report on Monday, December 8th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat, PureTech Health has a consensus rating of “Buy” and an average price target of GBX 508.

PureTech Health Trading Down 0.2%

The company has a market capitalization of £312.26 million, a P/E ratio of 7.60 and a beta of 1.02. The company has a debt-to-equity ratio of 45.82, a current ratio of 3.68 and a quick ratio of 2.51. The business’s 50-day moving average price is GBX 128.56 and its two-hundred day moving average price is GBX 128.47.

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia.